Retatrutide (20mg): overview
Retatrutide is an investigational triple agonist of the GLP-1, GIP and glucagon receptors, developed as a single molecule.
Research areas
- Metabolic and glycemic-regulation models
- Receptor-pharmacology comparisons with dual agonists such as tirzepatide
- Energy-expenditure and adipose-tissue studies
Specifications
- Form: lyophilized powder
- Amount per vial: 20 mg
- Testing: independent HPLC analysis by Janoshik Analytical; report in the product gallery
- Quantity pricing: the per-vial price falls at 2, 3, 4, 5 and 10 vials
Storage and handling
Keep the lyophilized powder sealed, cool, dry and away from light. After reconstitution with bacteriostatic water, store at 2 to 8 °C and use within the period your protocol specifies. Avoid repeated freeze-thaw cycles.
Shipping within Canada
Orders ship from Canada with tracking and discreet packaging. Free shipping on orders over $250 CAD, otherwise a $25 flat rate. Typical delivery is 2 to 5 business days. Payment by Interac e-Transfer.
Related research compounds
Frequently asked questions
Is Retatrutide for human use?
No. Retatrutide from ReVICO Labs is supplied for laboratory research only and is not authorized as a drug by Health Canada.
How is Retatrutide tested?
It is tested by Janoshik Analytical, an independent laboratory, using HPLC. The report is shown in the product gallery.
How is Retatrutide shipped in Canada?
From Canada, tracked and discreetly packed, typically within 2 to 5 business days. Free shipping over $250 CAD.
Research use only
This product is supplied for laboratory research only. It is not for human or veterinary use, is not authorized as a drug by Health Canada, and no dosing, medical or veterinary advice is provided. Buyers must be 18 or over.
There are no reviews yet.